Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & ResponsiveNew

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

for
Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer,
Location: Fairfax VA, Orlando FL, Irving TX
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07807345

Phase 1, Recruiting
Active & ResponsiveNew

Single FrAction Interstitial BreaSt BracHytherApy

for
Breast Cancer
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: Female

Age: 40 - 70+

Code: NCT07654257

Phase 2, Recruiting
Active & ResponsiveNew

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

for
Leptomeningeal Metastasis, Breast Cancer, Lung Cancer (NSCLC)
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT07789912

Recruiting
Active & ResponsiveNew

A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal

for
Cancer
Location: Scarborough ME
Sponsor: Scot Remick

Sex: All

Age: 18+

Code: NCT07089225

Recruiting
Active & ResponsiveNew

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

for
Cancer
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07811258

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for
Advanced Solid Tumor
Location: East Providence RI, Charleston SC, Huntersville NC,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06750185

Phase 1, Phase 2, Recruiting
Active & Responsive

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06559059

Recruiting
Active & Responsive

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

for
Breast Cancer Female
Location: New Haven CT, Newport News VA, Richmond VA, Fairfax VA,
Sponsor: University of Virginia

Sex: Female

Age: 65+

Code: NCT06507618

Phase 3, Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Weymouth MA, Boston MA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 60+

Code: NCT06377852

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, The Bronx NY, Montreal,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase 1, Recruiting
Active & Responsive

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

for
Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain,
Location: New York NY
Sponsor: Northwell Health

Sex: All

Age: 18 - 70+

Code: NCT03213002

Phase 1, Phase 2, Recruiting
Active & Responsive

UWCCC Molecular Tumor Board Registry

for
Hematologic Neoplasms, Solid Neoplasm
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT03023202

Recruiting
Active & Responsive

Breast Cancer, Reasoning, and Activity Intervention

for
Breast Cancer, Breast Neoplasms,
Location: Phoenix AZ
Sponsor: Mayo Clinic

Sex: Female

Age: 50+

Code: NCT04816006

Recruiting
Active & Responsive

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Columbus OH, Ann Arbor MI, Kansas City KS
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 45 - 70+

Code: NCT06195306

Phase 2, Recruiting
Active & Responsive

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

for
Solid Cancers
Location: Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 0+

Code: NCT05228106

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor
Location: Canton OH, Cleveland OH
Sponsor: Lamassu Bio Inc

Sex: All

Age: 18+

Code: NCT06578624

Phase 1, Phase 2, Recruiting
Active & Responsive

Yoga for Young Adults Affected by Cancer

for
Young Adult Cancer, Young Adult Oncology
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT05314803

Recruiting
Active & Responsive

Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery

for
Breast Cancer
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: Female

Age: 18 - 70+

Code: NCT06524895

Recruiting
Active & Responsive

PAS-004 in Patients With Advanced Solid Tumors

for
RAS Mutation, NF1 Mutation, RAF Mutation, Advanced Solid Tumors
Location: Fairfax VA, San Antonio TX
Sponsor: Pasithea Therapeutics Corp.

Sex: All

Age: 18+

Code: NCT06299839

Phase 1, Recruiting
Active & Responsive

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06066424

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial